Takeda

Takeda Offers $2.2 Billion to Settle Actos Drug Cases
Yahoo/Bloomberg
Wed, 04/1/15 - 08:38 am
Takeda
Actos
diabetes
bladder cancer
Who Will Be Orexigen's Ex-U.S. Partner? My Bet Is On Takeda
Seeking Alpha
Mon, 03/16/15 - 04:42 pm
Orexigen
Contrave
Mysimba
Takeda
Takeda Disagrees With Orexigen Over Data Disclosure
Forbes
Thu, 03/5/15 - 05:37 pm
Takeda
Orexigen
Contrave
Amgen's Kyprolis Outperforms Rival Drug In Study
Forbes
Mon, 03/2/15 - 08:05 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Takeda Sees Turnaround Next Year as New Drugs Bolster Growth
Bloomberg
Thu, 02/26/15 - 10:18 am
Takeda
Actos
Salix Suitors May Yet Emerge to Challenge Valeant: Real M&A
Bloomberg
Tue, 02/24/15 - 02:23 pm
Salix
Valeant Pharmaceuticals
M&A
Shire
Takeda
AstraZeneca
AbbVie
Actavis
Endo Health Solutions
Takeda makes an M&A move in Turkey
Fierce Pharma
Tue, 02/24/15 - 10:38 am
Takeda
M&A
Turkey
Neutec
Takeda Told to Pay $1.3 Million in Actos Punitive Damages
Bloomberg
Sat, 02/14/15 - 10:30 am
Takeda
Actos
lawsuits
Takeda says its 'breakthrough' cancer drug came through in Phase III
Fierce Biotech
Tue, 02/10/15 - 10:32 am
Takeda
ixazomib
Multiple Myeloma
Actos Bladder Cancer Lawsuit 2015 Update
Legal Examiner
Sat, 01/10/15 - 12:48 pm
Takeda
Actos
diabetes
Takeda Names Sanofi’s Andrew Plump as Head of Research
Bloomberg
Thu, 12/18/14 - 08:59 am
Takeda
Sanofi
R&D
Takeda targets gastrointestinal disease with its latest R&D deal
Fierce Biotech
Thu, 12/11/14 - 11:52 am
Takeda
R&D
irritable bowel syndrome
Assessing The Beginnings Of The Orexigen Launch Of Contrave
Seeking Alpha
Wed, 12/10/14 - 05:47 pm
Contrave
obesity
Orexigen
drug launches
Takeda
Six years and $8.8B later, Takeda is ditching the Millennium name
Fierce Biotech
Mon, 12/8/14 - 12:01 pm
Takeda
Millennium Pharmaceuticals
Takeda Announces Formalization of Takeda Oncology to Enhance Discovery, Development and Global Commercialization of Breakthrough Cancer Medicines
Pipeline Review
Sun, 12/7/14 - 10:01 am
Takeda
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Yahoo/BusinessWire
Sat, 12/6/14 - 11:15 am
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
Takeda Pharmaceuticals president quits
Chicago Business
Fri, 11/21/14 - 03:03 pm
Takeda
Sanofi Said to Consider Smith & Nephew, Takeda for CEO
Bloomberg
Wed, 11/19/14 - 10:11 am
Sanofi
Pharma CEOs
Takeda
Smith & Nephew
Takeda Ordered to Pay $155,000 for Destroying Actos Files
Bloomberg
Tue, 11/18/14 - 10:01 am
Takeda
Actos
Takeda's Millennium re-ups with Presage on cancer drug combo effort
Fierce Biotech
Wed, 11/12/14 - 11:46 am
Takeda
Millennium Pharmaceuticals
Presage Biosciences
cancer

Pages